Skip to main content

Novel approaches to unlock neuronal heterogeneity in health and disease

RYC2019-028501-I

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprogram Subprograma Estatal de Incorporación
Call Ramón y Cajal
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD AUTONOMA DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

CPT1A in AgRP neurons is required for sex-dependent regulation of feeding and thirst

  • Zagmutt, Sebastián
  • Mera, Paula
  • González-García, Ismael
  • Ibeas, Kevin
  • Romero, María del Mar
  • Obri, Arnaud
  • Martin, Beatriz
  • Esteve-Codina, Anna
  • Soler-Vázquez, M. Carmen
  • Bastias-Pérez, Marianela
  • Cañes, Laia
  • Augé, Elisabeth
  • Pelegri, Carme
  • Vilaplana, Jordi
  • Ariza, Xavier
  • García, Jordi
  • Martínez-González, José
  • Casals, Núria
  • López, Miguel
  • Palmiter, Richard
  • Sanz, Elisenda
  • Quintana, Albert
  • Herrero, Laura
  • Serra, Dolors
Background: Fatty acid metabolism in the hypothalamus has an important role in food intake, but its specific role in AgRP neurons is poorly understood. Here, we examined whether carnitinea palmitoyltransferase 1A (CPT1A), a key enzyme in mitochondrial fatty acid oxidation, affects energy balance. Methods: To obtain Cpt1aKO mice and their control littermates, Cpt1a mice were crossed with tamoxifen-inducible AgRP mice. Food intake and body weight were analyzed weekly in both males and females. At 12 weeks of age, metabolic flexibility was determined by ghrelin-induced food intake and fasting–refeeding satiety tests. Energy expenditure was analyzed by calorimetric system and thermogenic activity of brown adipose tissue. To study fluid balance the analysis of urine and water intake volumes; osmolality of urine and plasma; as well as serum levels of angiotensin and components of RAAS (renin–angiotensin–aldosterone system) were measured. At the central level, changes in AgRP neurons were determined by: (1) analyzing specific AgRP gene expression in RiboTag–Cpt1aKO mice obtained by crossing Cpt1aKO mice with RiboTag mice; (2) measuring presynaptic terminal formation in the AgRP neurons with the injection of the AAV1-EF1a-DIO-synaptophysin-GFP in the arcuate nucleus of the hypothalamus; (3) analyzing AgRP neuronal viability and spine formations by the injection AAV9-EF1a-DIO-mCherry in the arcuate nucleus of the hypothalamus; (4) analyzing in situ the specific AgRP mitochondria in the ZsGreen-Cpt1aKO obtained by breeding ZsGreen mice with Cpt1aKO mice. Two-way ANOVA analyses were performed to determine the contributions of the effect of lack of CPT1A in AgRP neurons in the sex. Results: Changes in food intake were just seen in male Cpt1aKO mice while only female Cpt1aKO mice increased energy expenditure. The lack of Cpt1a in the AgRP neurons enhanced brown adipose tissue activity, mainly in females, and induced a substantial reduction in fat deposits and body weight. Strikingly, both male and female Cpt1aKO mice showed polydipsia and polyuria, with more reduced serum vasopressin levels in females and without osmolality alterations, indicating a direct involvement of Cpt1a in AgRP neurons in fluid balance. AgRP neurons from Cpt1aKO mice showed a sex-dependent gene expression pattern, reduced mitochondria and decreased presynaptic innervation to the paraventricular nucleus, without neuronal viability alterations. Conclusions: Our results highlight that fatty acid metabolism and CPT1A in AgRP neurons show marked sex differences and play a relevant role in the neuronal processes necessary for the maintenance of whole-body fluid and energy balance., This study was supported by the Spanish Ministry of Economy and Competitiveness (MINECO) (SAF2017-83813-C3-1-R to DS and LH, cofunded by the European Regional Development Fund [ERDF] and PID2020-114953RB-C21 to LH and DS, RTI2018-094727-B-100 to JMG; SAF2017-88108-R to AQ; AEI (PID2020-114977RB-I00) to AQ, ERC-2014-StG-638106 to AQ, MICINN RYC2019-028501-I to ES; MICIU RTI2018-101838-J-I00 to ES; a doctoral fellowship to SZ, and a Juan de la Cierva-Incorporación Research Fellowship [IJCI-2016-28313] to PM and DS), the Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) (CB06/03/0001 to DS and LH), the Government of Catalonia (2014SGR465 to DS), and La Marató de TV3 (201627-30 to DS). AO is supported by a Miguel Servet contract (CP19/00083) from Instituto de Salud Carlos III co-financed by European Regional Development Fund [ERDF]. AE is funded by ISCIII /MINECO (PT17/0009/0019) and co-funded by FEDER.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Cannabidiol ameliorates mitochondrial disease via PPARγ activation in preclinical models

  • Puighermanal, Emma
  • Luna Sánchez, Marta
  • Gella, Alejandro
  • van der Walt, Gunter
  • Urpi, Andrea
  • Royo, María
  • Tena-Morraja, Paula
  • Appiah, Isabella
  • de Donato, María Helena
  • Menardy, Fabien
  • Bianchi, Patrizia
  • Esteve-Codina, Anna
  • Rodríguez-Pascau, Laura
  • Vergara, Cristina
  • Gómez-Pallarès, Mercè
  • Marsicano, Giovanni
  • Bellocchio, Luigi
  • Martinell, Marc
  • Sanz, Elisenda
  • Jurado, Sandra
  • Soriano, Francesc Xavier
  • Pizcueta, Pilar
  • Quintana, Albert
Mutations in mitochondrial energy-producing genes lead to a heterogeneous group of untreatable disorders known as primary mitochondrial diseases (MD). Leigh syndrome (LS) is the most common pediatric MD and is characterized by progressive neuromuscular affectation and premature death. Here, we show that daily cannabidiol (CBD) administration significantly extends lifespan and ameliorates pathology in two LS mouse models, and improves cellular function in fibroblasts from LS patients. CBD delays motor decline and neurodegenerative signs, improves social deficits and breathing abnormalities, decreases thermally induced seizures, and improves neuropathology in affected brain regions. Mechanistically, we identify peroxisome proliferator-activated receptor gamma (PPARγ) as a key nuclear receptor mediating CBD's beneficial effects, while also providing proof of dysregulated PPARγ expression and activity as a common feature in both mouse neurons and fibroblasts from LS patients. Taken together, our results provide the first evidence for CBD as a potential treatment for LS., This work was supported by three MINECO Ramon y Cajal fellowships (RYC2020-029596-I; E.P., RYC2019-028501-I; E.S., and RyC-2012-11873; A.Q.), a Beatriu de Pinós fellowship from University and Research Grants Catalan Management Agency (#2017BP00132; E.P.) Marie Sklodowska-Curie Individual Fellowship (H2020-MSCA-IF-2014-658352; E.S., H2020-MSCA-IF-2020-101030783, M.L-S., H2020-MSCA-COFUND-2014-665919, A.G.), pre-doctoral fellowships (2018FI_B 00452 to AU, 2024 FI-1 00645 to GvdW). E.P received funds from MICINN (PID2021-125079OA-I00). E.S received funds from MICIU Proyectos I + D + i “Retos Investigacion” (RTI2018-101838-J-I00) and Ministerio de Ciencia e Innovación (MICINN) (PID2019-107633RB-I00 and PID2022-142544OB-I00). A.Q. is a recipient of an ICREA Academia award and received funds from the European Research Council (Starting grant NEUROMITO, ERC-2014-StG-638106), Grants SAF2014-57981P; SAF2017-88108-R, PID2020-114977RB-I00, RTC2019-006825-1, PDC2021-121883-I0, RED2022-134786-T, funded by MICIU/AEI /10.13039/5011000110330 and by MICIU/AEI /10.13039/501100011033 and Next GenerationEU/ PRTR, AGAUR (2017SGR-323, 2021SGR-720), Fundació TV3-La Marató (202030), and “la Caixa” Foundation (ID 100010434), under the agreement LCF/PR/HR20/52400018., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Microglial response promotes neurodegeneration in the Ndufs4 KO mouse model of Leigh syndrome

  • Aguilar Ludwig, Kevin|||0000-0002-1452-2841
  • Comes, Gemma|||0000-0002-4074-7665
  • Canal Capdevila, Carla|||0000-0002-2150-4836
  • Quintana Romero, Albert|||0000-0003-1674-7160
  • Sanz Iglesias, Elisenda|||0000-0002-7932-8556
  • Hidalgo Pareja, Juan|||0000-0003-0921-1122
Leigh syndrome is a mitochondrial disease characterized by neurodegeneration, neuroinflammation, and early death. Mice lacking NDUFS4, a mitochondrial complex I subunit (Ndufs4 KO mice), have been established as a good animal model for studying human pathology associated with Leigh syndrome. As the disease progresses, there is an increase in neurodegeneration and neuroinflammation, thereby leading to deteriorating neurological symptoms, including motor deficits, breathing alterations, and eventually, death of the animal. However, despite the magnitude of neuroinflammation associated with brain lesions, the role of neuroinflammatory pathways and their main cellular components have not been addressed directly as relevant players in the disease pathology. Here, we investigate the role of microglial cells, the main immune cells of the CNS, in Leigh-like syndrome pathology, by pharmacologically depleting them using the colony-stimulating factor 1 receptor antagonist PLX3397. Microglial depletion extended lifespan and delayed motor symptoms in Ndufs4 KO mice, likely by preventing neuronal loss. Next, we investigated the role of the major cytokine interleukin-6 (IL-6) in the disease progression. IL-6 deficiency partially rescued breathing abnormalities and modulated gliosis but did not extend the lifespan or rescue motor decline in Ndufs4 KO mice. The present results show that microglial accumulation is pathogenic, in a process independent of IL-6, and hints toward a contributing role of neuroinflammation in the disease of Ndufs4 KO mice and potentially in patients with Leigh syndrome.